- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/11 - Orthomyxoviridae, e.g. influenza virus
Patent holdings for IPC class C07K 14/11
Total number of patents in this class: 619
10-year publication summary
|
23
|
38
|
42
|
39
|
34
|
36
|
42
|
41
|
24
|
32
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Icahn School of Medicine at Mount Sinai | 1053 |
18 |
| Medicago Inc. | 124 |
18 |
| Sanofi Pasteur Inc. | 218 |
17 |
| Aramis Biotechnologies Inc. | 57 |
17 |
| Janssen Vaccines & Prevention B.V. | 266 |
14 |
| FluGen, Inc. | 39 |
12 |
| Intervet International B.V. | 1342 |
11 |
| Longhorn Vaccines and Diagnostics, LLC | 90 |
11 |
| Intervet Inc. | 947 |
10 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3019 |
10 |
| Duke University | 3191 |
8 |
| AVIR Green Hills Biotechnology Research Development Trade AG | 10 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3357 |
6 |
| Seqirus Inc. | 250 |
6 |
| The Regents of the University of California | 20924 |
4 |
| Massachusetts Institute of Technology | 10313 |
4 |
| Academia Sinica | 961 |
4 |
| Folia Biotech Inc. | 10 |
4 |
| Georgia State University Research Foundation, Inc. | 361 |
4 |
| Her Majesty The Queen in Right of Canada AS represented by The Minister of Health | 53 |
4 |
| Other owners | 431 |